Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
http://link.springer.com/article/10.1186/1471-2369-14-44/fulltext.html
Reference13 articles.
1. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Med Qual. 1999, 14: 270-277. 10.1177/106286069901400607.
2. Attallah N, Osman-Malik Y, Frinak S, Besarab A: Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Am J Kidney Dis. 2006, 47: 644-654. 10.1053/j.ajkd.2005.12.025.
3. Johnson DW, Pollock CA, Macdougall IC: Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology (Carlton ). 2007, 12: 321-330. 10.1111/j.1440-1797.2007.00810.x.
4. Drueke T: Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant. 2001, 16 (Suppl 7): 25-28. 10.1093/ndt/16.suppl_7.25.
5. Kwack C, Balakrishnan VS: Managing erythropoietin hyporesponsiveness. Semin Dial. 2006, 19: 146-151. 10.1111/j.1525-139X.2006.00141.x.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States;Kidney International Reports;2023-12
2. Hyporesponsiveness to Erythropoietin-Stimulating Agents: Possible Solutions;Updates on Hemodialysis;2023-09-27
3. Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoiesis-stimulating agents on iron metabolism and inflammation in patients undergoing dialysis: A systematic review and meta-analysis;Heliyon;2023-04
4. Resistance to Erythropoiesis Stimulating Agent (ESA) Treatment;Handbook of Dialysis Therapy;2023
5. Challenging patient phenotypes in the management of anaemia of chronic kidney disease;International Journal of Clinical Practice;2021-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3